Skip to main content
EP

Eleuthra Photonics Inc.

Eleuthra Photonics develops multimodal nonlinear imaging technology for real-time digital histopathology, utilizing a single excitation laser to produce five imaging modalities without the need for staining. This approach significantly reduces the time required for tissue sample analysis while preserving molecular integrity, enhancing diagnostic accuracy for histopathologists and improving patient outcomes.

Champaign, United StatesFounded 2023310+ followers
Updated 4 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

Traditional histopathology requires time-consuming staining processes that can compromise the molecular integrity of tissue samples. The lengthy preparation and analysis workflows can delay diagnoses and potentially impact patient outcomes.

Solution

Eleuthra Photonics offers a multimodal nonlinear imaging technology that enables real-time digital histopathology without the need for staining. Their microscopes use a single excitation laser to generate five nonlinear imaging modalities, providing both structural and metabolic information from a tissue sample. The automated sectioning and imaging process significantly reduces the time required for tissue analysis, while preserving the sample's molecular integrity. This approach enhances diagnostic accuracy and streamlines workflows for histopathologists.

Target Audience

The primary target audience includes histopathologists, surgeons, and other medical professionals involved in tissue sample analysis and diagnostics.

Features

  • Multimodal nonlinear imaging using a single excitation laser
  • Generates five imaging modalities for comprehensive tissue analysis
  • Stain-free imaging preserves molecular integrity of the sample
  • Automated tissue sectioning and imaging for rapid processing
  • Real-time digital histopathology capabilities
This profile is AI-generated and may contain inaccuracies.